{"id":62147,"date":"2025-11-05T16:03:49","date_gmt":"2025-11-05T15:03:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/"},"modified":"2025-11-05T16:03:49","modified_gmt":"2025-11-05T15:03:49","slug":"navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/","title":{"rendered":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year"},"content":{"rendered":"
\n

\nNavitus MedicareRx maintained a 4.5 out of 5 Part D Star Rating for 2026, recognizing ongoing clinical quality and excellent service to beneficiaries<\/i>\n<\/p>\n

MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation\u2019s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D Star Rating from the Centers for Medicare & Medicaid Services (CMS). This is the highest score in the nation among PBM-sponsored prescription drug plans and marks the tenth consecutive year leading the category.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nMedicare evaluates plans each year based on a 5-star rating program. Navitus MedicareRx offers Part D plans for employer groups and has consistently delivered exceptional results in Part D clinical outcomes measures. Using advanced analytics and reporting, clinicians identify beneficiaries who are struggling with adherence and can benefit from additional support. Once identified, outreach and education are provided through medication therapy management and adherence programs to remove barriers and support positive behavior change.\n<\/p>\n

\nIn addition to clinical care, the 4.5 out of 5 Part D Star Rating highlights the superior customer service Navitus offers, as measured by the CMS-required CAHPS (Consumer Assessment of Healthcare Providers and Systems) survey. Navitus consistently earns high marks in CAHPS surveys, with specialized teams empowered to resolve issues quickly and compassionately, ensuring Medicare beneficiaries receive the care and attention they deserve.\n<\/p>\n

\n\u201cTen years as the nation\u2019s highest-rated PBM-sponsored PDP EGWP is the result of the incredible focus of our associates that deliver on our mission each day,\u201d said David Fields, President and CEO, Navitus Health Solutions. \u201cI\u2019m extremely proud of our teams for their dedication to exceptional service for retirees and Medicare beneficiaries to help ensure appropriate medication use, adherence, and improved health.\u201d\n<\/p>\n

\nNavitus MedicareRx (PDP), offered by Dean Health Insurance, Inc., is a prescription drug plan with a Medicare contract. For more information on Star Ratings, visit www.medicare.gov<\/a>.\n<\/p>\n

\nAbout Navitus
\n
<\/b>Navitus remains the nation\u2019s first transparent, pass-through pharmacy benefit manager (PBM). It uniquely brings clarity to drug pricing and takes costs out of the drug supply chain. Unlike traditional PBMs that generate profit by retaining an undisclosed portion of rebates and discounts negotiated with drug manufacturers and pharmacies, Navitus passes along the complete savings to clients, enabling them to make medication more affordable for their members. Navitus was established more than 20 years ago by Navitus Health Solutions, LLC, a pioneering pharmacy solutions company. The organization delivers a range of services through portfolio brands including Navitus, Lumicera and Archimedes. Owned by SSM Health and Costco, Navitus Health Solutions serves over 18 million lives across 800 clients including employers, unions, government plans, payers and health systems. For more information, please visit www.navitus.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor questions and media inquiries, contact Navitus@aircoverpr.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Navitus MedicareRx maintained a 4.5 out of 5 Part D Star Rating for 2026, recognizing ongoing clinical quality and excellent service to beneficiaries MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation\u2019s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62147","6":"format-standard","7":"category-industry"},"yoast_head":"\nNavitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Navitus MedicareRx maintained a 4.5 out of 5 Part D Star Rating for 2026, recognizing ongoing clinical quality and excellent service to beneficiaries MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation\u2019s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-05T15:03:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year\",\"datePublished\":\"2025-11-05T15:03:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/\"},\"wordCount\":470,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251105351338\\\/en\\\/2632906\\\/22\\\/logo_NAV-2023-OBIP_horz_color_01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/\",\"name\":\"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251105351338\\\/en\\\/2632906\\\/22\\\/logo_NAV-2023-OBIP_horz_color_01.jpg\",\"datePublished\":\"2025-11-05T15:03:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251105351338\\\/en\\\/2632906\\\/22\\\/logo_NAV-2023-OBIP_horz_color_01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251105351338\\\/en\\\/2632906\\\/22\\\/logo_NAV-2023-OBIP_horz_color_01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/","og_locale":"en_US","og_type":"article","og_title":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend","og_description":"Navitus MedicareRx maintained a 4.5 out of 5 Part D Star Rating for 2026, recognizing ongoing clinical quality and excellent service to beneficiaries MADISON, Wis.–(BUSINESS WIRE)–Navitus, the nation\u2019s first and largest transparent, pass-through pharmacy benefit manager (PBM), announced today that its prescription drug plan Navitus MedicareRx (PDP) maintained a 4.5 out of 5 Part D ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/","og_site_name":"Pharma Trend","article_published_time":"2025-11-05T15:03:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year","datePublished":"2025-11-05T15:03:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/"},"wordCount":470,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/","url":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/","name":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg","datePublished":"2025-11-05T15:03:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251105351338\/en\/2632906\/22\/logo_NAV-2023-OBIP_horz_color_01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/navitus-medicarerx-pdp-remains-nations-highest-rated-pbm-sponsored-pdp-egwp-for-tenth-consecutive-year\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Navitus MedicareRx (PDP) Remains Nation\u2019s Highest-Rated PBM-Sponsored PDP EGWP for Tenth Consecutive Year"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62147"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62147\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}